3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
37
Neoplasm Metastasis
6
Neoplasms by Site
2
Neoplasms
2
Hereditary Sensory and Autonomic Neuropathies
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Diseases
2
Anatomic Stage II Breast Cancer AJCC v8
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Sarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Locoregional Recurrence
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Liposarcoma
1
Leiomyosarcoma
1
Head and Neck Neoplasms
1
HR+/HER2- Breast Cancer
1
HER2 Negative Breast Cancer Not Immediately Operated
1
HER2 Negative Breast Cancer
1
Glioma
1
Glioblastoma
1
Interventions
Temozolomide
5
Specimen Handling
2
Radiotherapy
2
Magnetic Resonance Spectroscopy
2
vocimagene amiretrorepvec
1
trametinib
1
dabrafenib
1
abexinostat
1
Vorinostat
1
Transurethral Resection of Bladder
1
Surgical Procedures, Operative
1
Standard of Care
1
Spinal Puncture
1
Restraint, Physical
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Protons
1
Proton Therapy
1
Practice Guidelines as Topic
1
Outcome Assessment, Health Care
1
Observational Studies as Topic
1
Ketoconazole
1
Irinotecan
1
Heart Rate
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Eflornithine
1
Diphtheria-Tetanus Vaccine
1
DNA
1
Craniotomy
1
Carmustine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Oligodendroglioma
×
ribociclib
×
90 days
×
Clear all
No trials found.